Clinical Trials Directory

Trials / Recruiting

RecruitingNCT06731114

"Additional Effects of Sternocleidomastoid Release Along With Suboccipital Muscle Release in Management of Cervicogenic Headache'

Status
Recruiting
Phase
N/A
Study type
Interventional
Enrollment
54 (estimated)
Sponsor
Foundation University Islamabad · Academic / Other
Sex
All
Age
18 Years – 45 Years
Healthy volunteers
Not accepted

Summary

This study is a randomised control trial and the purpose of this study is to determine the "Additional effects of sternocleidomastoid release along with suboccipital muscle release in management of cervicogenic headache".

Detailed description

Cervicogenic headache is a common headache that causes disability and affects everyday activities. Headache related disorders are the second most common reason for years lived with disability all over the world. According to the latest International Headache Society model, cervicogenicheadache (CGH) is a secondary headache having C1-C2 dysfunction. There is marked limitation in cervical ROM specially rotation. Treatment indicated involves use of electrotherapy and thermal modalities. In addition, use of different manual therapy techniques are advocated to eliminate the root cause i.e. C1-C2 dysfunction treating. patients with cervicogenic headache are mostly presented with forward head posture and weak deep neck flexors which may excerbate the headache symptoms.Therefore The purpose of this study is to determine the ""Additional effects of sternocleidomastoid release along with suboccipital muscle release in management of cervicogenic headache

Conditions

Interventions

TypeNameDescription
PROCEDURESuboccipital muscle releaseSuboccipital muscle release.6 consecutive sessions for 2 weeks • Frequency:( 3mins 3 reps) 9 mins .12 sessions in total
PROCEDUREConventional physical therapyTENS and hot pack for 10 mins 6 days a week for consecutive 2 weeks
PROCEDURESternocleidomastoid releaseFrequency: 5 mins of SCM release and 9 mins (3 mins 3 reps )of suboccipital release. 12 sessions in total.

Timeline

Start date
2024-07-15
Primary completion
2025-07-15
Completion
2025-07-15
First posted
2024-12-12
Last updated
2024-12-12

Locations

1 site across 1 country: Pakistan

Source: ClinicalTrials.gov record NCT06731114. Inclusion in this directory is not an endorsement.